These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38347847)

  • 1. Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma.
    Trimboli P; Peloni G; Confalonieri D; Gamarra E; Piticchio T; Frasca F; Makovac P; Piccardo A; Ruinelli L
    Front Oncol; 2024; 14():1278816. PubMed ID: 38347847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
    Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
    Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients.
    Weber T; Poplawski A; Vorländer C; Dotzenrath C; Ringelband R; Schabram J; Passler C; Zielke A; Schlegel N; Nies C; Krenz D; Jähne J; Schwab R; Bartsch DK; Binnebösel M; Kemen M; Klinger C; Buhr H; Lorenz K
    Eur J Endocrinol; 2022 Jan; 186(2):223-231. PubMed ID: 34871180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules: A systematic review and meta-analysis.
    Piticchio T; Frasca F; Trimboli P
    Rev Endocr Metab Disord; 2023 Aug; 24(4):685-694. PubMed ID: 37254023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
    Rosario PW; Calsolari MR
    Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Utility of Procalcitonin for Sporadic Medullary Thyroid Carcinoma in Patients with Nodular Disease and Mild or Moderate Hypercalcitoninemia.
    Rosario PW; Mourão GF
    Horm Metab Res; 2022 Apr; 54(4):220-223. PubMed ID: 35413742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
    Eckelt F; Pfaeffle R; Kiess W; Kratzsch J
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules.
    Broecker-Preuss M; Simon D; Fries M; Kornely E; Weber M; Vardarli I; Gilman E; Herrmann K; Görges R
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin Screening in Nodular Thyroid Disease: Is There a Definitive Answer?
    Silvestre C; Sampaio Matias J; Proença H; Bugalho MJ
    Eur Thyroid J; 2019 Apr; 8(2):79-82. PubMed ID: 31192146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Serum Calcitonin in Patients with Thyroid Nodules ≤ 1 cm Without an Indication for Fine-Needle Aspiration.
    Rosario PW; Mourão GF; Calsolari MR
    Horm Metab Res; 2020 Apr; 52(4):216-219. PubMed ID: 32168524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal Serum Calcitonin, After Calcium Stimulation, and in the Needle Washout of Patients with Thyroid Nodules and Mild or Moderate Basal Hypercalcitoninemia.
    Rosario PW; Calsolari MR
    Horm Metab Res; 2017 Feb; 49(2):129-134. PubMed ID: 28166595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
    Zhang H; Zhang D; Sui C; Li J; Li C; He Q; Du R; Zhao Y; Fu Y; Zhou L; Wang T; Dionigi G; Liang N; Sun H
    Ann Transl Med; 2022 Jun; 10(12):709. PubMed ID: 35845523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature.
    Contarino A; Dolci A; Maggioni M; Porta FM; Lopez G; Verga U; Elli FM; Iofrida EF; Cantoni G; Mantovani G; Arosio M
    Front Endocrinol (Lausanne); 2022; 13():866572. PubMed ID: 35574005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
    Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
    Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.
    Bae YJ; Schaab M; Kratzsch J
    Recent Results Cancer Res; 2015; 204():117-37. PubMed ID: 26494386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
    Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.